A detailed history of Hexagon Capital Partners LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 108 shares of ZTS stock, worth $17,787. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108
Previous 36 200.0%
Holding current value
$17,787
Previous $6,000 250.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$172.58 - $196.48 $12,425 - $14,146
72 Added 200.0%
108 $21,000
Q2 2024

Jul 12, 2024

BUY
$145.54 - $178.83 $873 - $1,072
6 Added 20.0%
36 $6,000
Q1 2024

Apr 18, 2024

BUY
$165.67 - $199.94 $4,970 - $5,998
30 New
30 $5,000
Q3 2023

Oct 23, 2023

BUY
$167.14 - $192.77 $1,002 - $1,156
6 Added 85.71%
13 $2,000
Q4 2022

Jan 13, 2023

BUY
$131.14 - $157.47 $917 - $1,102
7 New
7 $0
Q2 2022

Jul 21, 2022

BUY
$155.97 - $200.09 $779 - $1,000
5 New
5 $1,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.